Description

Renalgan (sodium metamizole, fenpiverinium bromide) tablets №10

Ingredients

Active ingredients: Each tablet contains sodium metamizole and fenpiverinium bromide.

Dosage

Dosage: The usual dose is 1-2 tablets taken orally every 6-8 hours as needed. Do not exceed 6 tablets in 24 hours.

Indications

Indications: Renalgan tablets are indicated for the relief of moderate to severe pain and discomfort.

Contraindications

Contraindications: Do not use Renalgan tablets if you are allergic to any of the ingredients, have a history of blood disorders, or are pregnant.

Directions

Directions: Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Renalgan tablets have been studied in clinical trials for their efficacy in pain management. Research has shown that the combination of sodium metamizole and fenpiverinium bromide provides effective relief from various types of pain, including musculoskeletal pain and postoperative pain.

Additional Information

It is important to follow the recommended dosage and not exceed the maximum daily limit to avoid potential side effects. If you experience any adverse reactions, discontinue use and consult a healthcare professional.

Pharmacological Effects: Sodium metamizole is a non-opioid analgesic with antipyretic properties, while fenpiverinium bromide is an anticholinergic agent that helps to relieve smooth muscle spasms. The combination of these two ingredients provides a synergistic effect in pain relief.

Clinical Trials: In a double-blind, placebo-controlled study, Renalgan tablets were found to significantly reduce pain intensity and improve overall patient satisfaction compared to placebo. The rapid onset of action and long duration of effect make Renalgan a valuable option for pain management.